SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $99

Raymond James analyst Jayson Bedford maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $90 to $99.

Benzinga · 01/23/2020 12:48

Raymond James analyst Jayson Bedford maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $90 to $99.